Ikuto Tsukiyama
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effects of consultations and interventions in a pharmacist-led outpatient clinic on duration of treatment and adverse events with osimertinib.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 29, 2025
Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 28, 2023
Cost-utility analysis of aprepitant for patients who truly need it in Japan.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 22, 2018
Multivariate analysis of risk factors for cisplatin-induced nephrotoxicity in gynecological cancer.
Journal: The journal of obstetrics and gynaecology research
Published: February 28, 2017
The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: January 05, 2017
A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan.
Journal: Journal of gastrointestinal cancer
Published: October 28, 2016
Dose Reduction versus Dose-interval Prolongation in Eribulin Mesilate Monotherapy in Patients with Metastatic Breast Cancer: A Retrospective Comparative Study.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: April 05, 2016
Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
Journal: Anticancer research
Published: February 12, 2016
Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 03, 2015
A smear method for measuring anti-cancer drugs residues in hospitals
Journal: Sangyo eiseigaku zasshi = Journal of occupational health
Published: August 14, 2015
Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.
Journal: Anticancer research
Published: August 09, 2015
Last Updated: 09/26/2026